RSS Feeds
Search

Out-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

Displaying 1..10 of 179 - per page Next page
Order by
Diclofenac potassium immediate release tablets 25 and 50 mg
25 and 50 mg diclofenac K film coated immediate release tablets More
Cellophil™ Biomedical Polymers - New and superior biomedical polymers for drug delivery and new standards in the medical device industry
Cellophil™ is a platform of novel polymers based on amino-acid groups. The platform polymers show superior biocompatibility and can be loaded with drugs for controlled release. More
Topical Diclofenac
Topical Diclofenac formulations for the treatment of inflammatory and painful conditions More
Diclofenac Sodium 25 mg. immediate release tablets
25mg dosage strenght for the OTC market in film coated tablets More
Ketoprofen Patch
Adhesive Patch of 90 sq. cm. and containing as active ingredient 100 mg. of ketoprofen for the local treatment of traumatic injuries and extra-articular rheumatism More
Capsaicin patch
Capsaicin, the active ingredient found in red-hot peppers, is used mainly for the relief of chronic pain of rheumatoid arthritis and osteoarthritis More
APR Fastest for Migraine
The First Line of Therapy in Severe Migraine Attacks More
Diclofenac potassium oral drops at 5%
The first pure, immediate release (Tmax in 13,68 min), completely palatable and free from aftertaste diclofenac potassium formulation in drops at 5% available on the market More
Technology for Immediate release of oral forms based on Diclofenac
New pharmaceutical compositions for oral use containing diclofenac together with alkali metal carbonates and bicarbonates and particular flavouring substances. More
Multilayered controlled release oral solid pharmaceutical forms
Multilayered controlled release oral solid pharmaceutical composition in tablet form suitable for oral administration comprising at least two layers containing active material in association with excipients and additives. More
Displaying 1..10 of 179 - per page Next page
Order by

Related Reports

Market Research Reports provided by reports.innovaro.com
National Institute of Arthritis and Musculoskeletal and Skin Diseases – Developmental Therapeutics Review – Q4 2010
Nov 2010 - 40 pages - $500
National Institute of Arthritis and Musculoskeletal and Skin Diseases – Developmental Therapeutics Review – Q4 2010
Dec 2010 - 84 pages - $500
Musculoskeletal Pain Global Clinical Trials Review, Q1, 2011
Mar 2011 - 34 pages - $1,000
Musculoskeletal Disorders Pipeline Databook - November 2011
Nov 2011 - 7 pages - $3,835
Musculoskeletal Transplant Foundation - Medical Equipment - Deals and Alliances Profile
Mar 2011 - 16 pages - $250
Deals and alliances in musculoskeletal diseases
Jun 2006 - 378 pages - $2,495
New Drug Futures 2009
Apr 2009 - 450 pages - $3,490
Musculoskeletal Disorders Therapeutics to 2016 - Introduction of Monoclonal Antibodies with First - in - class Mechanism of Action to Increase Treatment Options in Osteoporosis and Rheumatoid Arthritis
Oct 2010 - 169 pages - $3,500
Musculoskeletal Pain - Pipeline Review, H2 2011
Oct 2011 - 134 pages - $500
Musculoskeletal Pain - Pipeline Review, Q1 2011
Mar 2011 - 82 pages - $500
More Related Market Research Reports >>>

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2012 Innovaro Europe Ltd Innovaro Corporation All rights reserved. Terms and Conditions | Contact us